Danaher Corporation $DHR Shares Bought by USS Investment Management Ltd

USS Investment Management Ltd raised its stake in Danaher Corporation (NYSE:DHR) by 7.6% in the fourth quarter, HoldingsChannel reports. The fund owned 109,135 shares of the conglomerate’s stock after purchasing an additional 7,724 shares during the period. USS Investment Management Ltd’s holdings in Danaher were worth $24,992,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently bought and sold shares of DHR. JPL Wealth Management LLC acquired a new position in Danaher in the third quarter valued at approximately $25,000. Elevated Capital Advisors LLC acquired a new position in Danaher in the fourth quarter valued at approximately $26,000. WFA of San Diego LLC acquired a new position in Danaher in the second quarter valued at approximately $26,000. ANTIPODES PARTNERS Ltd acquired a new position in Danaher in the third quarter valued at approximately $27,000. Finally, Hilton Head Capital Partners LLC acquired a new position in Danaher in the fourth quarter valued at approximately $27,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. UBS Group cut their price objective on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. JPMorgan Chase & Co. reduced their target price on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. TD Cowen reduced their target price on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Rothschild & Co Redburn set a $205.00 target price on Danaher in a research note on Friday, April 17th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average price target of $233.61.

Key Danaher News

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher closed its $9.9 billion acquisition of Masimo, expanding its diagnostics and patient-monitoring portfolio with AI-enabled sensor technologies that could support longer-term growth. Danaher Boosts Product Portfolio With the Acquisition of Masimo
• Positive Sentiment: Cepheid, a Danaher company, donated Xpert Hemorrhagic Fever panel tests to support Ebola outbreak response in Africa, highlighting the company’s diagnostic relevance and public-health role. Cepheid Delivers Xpert Hemorrhagic Fever Panel Tests to Africa
• Positive Sentiment: Analysts noted strong performance in Danaher’s biotechnology unit, with bioprocessing demand and equipment orders rising, which supports the company’s 2026 growth outlook. Strong Performance Continues at DHR’s Biotechnology Unit: What’s Next?

Danaher Stock Down 0.1%

Shares of DHR opened at $179.95 on Monday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The stock has a market capitalization of $127.37 billion, a price-to-earnings ratio of 34.81, a PEG ratio of 2.30 and a beta of 0.81. The stock has a 50 day moving average price of $180.93 and a 200 day moving average price of $204.62.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period in the previous year, the business earned $1.88 earnings per share. The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. Equities research analysts forecast that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is presently 30.95%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.